DNA methyltransferase mediates the hypermethylation of the microRNA 34a promoter and enhances the resistance of patient-derived pancreatic cancer cells to molecular targeting agents
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 160, 105071
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Cross-Talk between Dnmt2-Dependent tRNA Methylation and Queuosine ModificationBiomolecules, 2017
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trialThe Lancet, 2017
- Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cellsCancer Letters, 2016
- Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agentsBiochimica et Biophysica Acta (BBA) - General Subjects, 2016
- Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic CancerThe Oncologist, 2016
- MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC CellsCurrent Cancer Drug Targets, 2015
- MEIS1 functions as a potential AR negative regulatorExperimental Cell Research, 2014
- FBI-1 Enhances ETS-1 Signaling Activity and Promotes Proliferation of Human Colorectal Carcinoma CellsPLOS ONE, 2014
- LINE-1 ORF-1p functions as a novel HGF/ETS-1 signaling pathway co-activator and promotes the growth of MDA-MB-231 cellCellular Signalling, 2013
- Distant metastasis occurs late during the genetic evolution of pancreatic cancerNature, 2010